Publications

High-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting in mantle cell lymphoma: a 10-year update of the R-HDS regimen.

Magni M

Bone Marrow Transplant. 2008 Oct 27;43(6):509-11. doi: 10.1038/bmt.2008.349

Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study.

Di Nicola M

Blood. 2008 Sep 22;113(1):18-27. doi: 10.1182/blood-2008-06-165654

High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.

Devizzi L

J Clin Oncol. 2008 Oct 14;26(32):5175-82. doi: 10.1200/JCO.2008.16.8294

The effect of artificial antigen-presenting cells with preclustered anti-CD28/-CD3/-LFA-1 monoclonal antibodies on the induction of ex vivo expansion of functional human antitumor T cells.

Zappasodi R

Haematologica. 2008 Aug 25;93(10):1523-34. doi: 10.3324/haematol.12521

Highly efficient gene transfer into mobilized CD34+ hematopoietic cells using serotype-5 adenoviral vectors and BoosterExpress Reagent.

Lavazza C

Exp Hematol. 35(6):888-97.

Long-term lymphoma survivors following high-dose chemotherapy and autograft: evidence of permanent telomere shortening in myeloid cells, associated with marked reduction of bone marrow hematopoietic stem cell reservoir.

Rocci A

Exp Hematol. 35(4):673-81.

Forced expression of RDH10 gene retards growth of HepG2 cells.

Rossi E

Cancer Biol Ther. 2007 Feb 25;6(2):238-44.

Placental growth factor-1 potentiates hematopoietic progenitor cell mobilization induced by granulocyte colony-stimulating factor in mice and nonhuman primates.

Carlo-Stella C

Stem Cells. 2006 Sep 28;25(1):252-61.

Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand.

Carlo-Stella C

Hum Gene Ther. 17(12):1225-40.

CD52 antigen expressed by malignant plasma cells can be targeted by alemtuzumab in vivo in NOD/SCID mice.

Carlo-Stella C

Exp Hematol. 34(6):721-7.